News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

$60 Million Later, Biotech Altea Therapeutics Calls it Quits


12/9/2011 8:16:02 AM

Atlanta Business Chronicle by Urvaksh Karkaria, Staff Writer

A life sciences company that raised more than $60 million in venture capital, and once contemplated going public, has flamed out.

Atlanta-based Altea Therapeutics Corp. was developing a proprietary, noninvasive method to deliver therapeutic proteins, conventional drugs and vaccines through the skin by creating “micropores” on the skin’s surface. Like some of its peers, Altea ran out of money before it could get there.

“The product was doing great, the wwtechnology was doing great, the company was doing great,” said Altea’s former chief executive, Eric Tomlinson.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES